Replacing animal-based hydrolysates in biopharmaceutical processes with animal- free and chemically defined alternatives to reduce regulatory concerns by Inman III, Floyd L.
REPLACING ANIMAL-BASED HYDROLYSATES IN BIOPHARMACEUTICAL PROCESSES WITH 
ANIMALFREE AND CHEMICALLY DEFINED ALTERNATIVES TO REDUCE REGULATORY CONCERNS 
 




Many biopharmaceutical products are routinely manufactured with biological systems (i.e. mammalian and/or 
microbial cell lines) and consequently, concerns regarding the product’s quality, efficacy and safety are raised. 
Due to the complexity of these “biological systems,” many regulatory agencies intensely scrutinize these 
products prior to approving them for human usage. When working with biological systems, it is presumed that 
the cultivating medium plays a significant role in product manufacturing; specifically, in terms of product efficacy, 
quality and titer. To achieve cost efficiency and titer requirements in commercial scale processes, protein 
hydrolysates are classically used complex sources of nitrogen to support cellular growth and productivity. Over 
the past century, the main types of protein hydrolysates are typically made from animal-based materials such as 
milk (e.g. casein), muscle tissue, and organ meats (i.e. heart, brain, spleen). These animal-based hydrolysates 
have been shown to play a crucial role in vaccine production and food fermentations where high-density, 
productive cultures are required to achieve the final output. However, with incidences of bovine spongiform 
encephalopathy occurring over the past decade, regulatory bodies have become more concerned with the use 
of animal-based materials in fear of transmitting animal diseases to humans. To address these concerns, many 
hydrolysate suppliers are starting to produce vegetable-based hydrolysates (i.e. soy, wheat, corn, pea, etc.) and 
yeast extracts. In addition to these vegetable sourced hydrolysates, a handful of companies are developing 
chemically-defined media and/or supplements to completely remove hydrolysates from media formulations. As a 
leading, global manufacturer of complex nitrogen sources, Kerry offers a multitude of various protein 
hydrolysates, yeast extracts and chemically defined media to meet the needs and desires of numerous markets. 
 
 
